80 likes | 81 Vues
According to our new marketresearch study titled ?Chronic Cough Market ?Global Analysis andForecast ? by Drug Class, Route of Administration, and Distribution Channel? the global chronic cough market is expected to reachUS$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimatedto grow at a CAGR of 7.8% from 2020 to 2027. The report highlights the trendsprevalent in the global chronic cough market, and the drivers and deterrents pertainingto its growth.
E N D
Chronic Cough Market Global Analysis and Forecast to 2028 Published Date : Jun 2020 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class); Route of Administration (Oral, Injections, Inhalation, Other and Route of Administration); Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy); and Geography 2
Email: sales@theinsightpartners.com Chronic Cough Market Overview The Chronic Cough Market is expected to reach US$ 9,854.8 million by 2027 from US$ 5,430.0 million in 2019; it is estimated to grow at a CAGR of 7.8% from 2020 to 2027. Chronic cough isdefined as a persistent cough that lasts long up to 6-8 weeks. It significantlyaffects the life of the patients by interrupting sleep, creating vomitingsensation, light-headedness, and even rib fractures. It is caused due tomultiple reasons such as infections, asthma, and gastro esophageal refluxdisease (GERD). The chronic cough market growth is attributed to factors suchas rising incidences of chronic cough and growing product developments to treatchronic cough are expected to drive the growth of the market. However, productrecalls is the major factor hindering the market growth. 3
Email: sales@theinsightpartners.com Key Segment Market Segment By Type:- By Drug Class (Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, and Other Drug Class) Route of Administration (Oral, Injections, Inhalation, Other and Route of Administration) Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy) Download Sample Here 4
Email: sales@theinsightpartners.com $50,000 Chronic Cough Market Value $40,000 $30,000 CAGR of 7.8% $20,000 (2020 - 2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles Novartis AG Teva Pharmaceutical Industries Ltd GlaxoSmithKline plc. Bayer AG, Mylan N.V. Amneal Pharmaceuticals, Inc. Cipla Inc. Reckitt Benckiser Group plc Sun Pharmaceutical Industries Ltd Aurobindo Pharma Ltd Download Sample Here 6
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com